Dietary Advice in British General Practice
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Drug Safety Oversight Board Members
April 29, 2021 Drug Safety Oversight Board (DSOB) Roster Chair • Douglas Throckmorton, M.D., Deputy Director for Regulatory Programs Center for Drug Evaluation and Research Executive Director • Terry Toigo, R.Ph, MBA Associate Director for Drug Safety Operations, Center for Drug Evaluation and Research Food and Drug Administration Center for Drug Evaluation and Research (CDER) Office of the Center Director (OCD) Primary Member: • Robert Temple, M.D., Deputy Director for Clinical Science Office of New Drugs (OND) Primary Member: • Mary Thanh Hai, M.D., Deputy Director, Office of New Drugs Alternate Members: • Peter Stein, M.D., Director, Office of New Drugs • Ellis Unger, M.D., Director, Office of Office of Cardiology, Hematology, Endocrinology, and Nephrology (OCHEN) Office of Medical Policy (OMP) Primary Member: • Jacqueline Corrigan-Curay, Director Alternate Member: • Leonard V. Sacks, Mgr. Supervisory Medical Officer Office of Generic Drugs (OGD) Primary Member: • Linda Forsyth, M.D., Division of Clinical Review Alternate Member: • Vacant Office of Surveillance and Epidemiology (OSE) Primary Members: • Mark I. Avigan, M.D., Associate Director for Critical Path Initiatives • Judy Zander, M.D., Director, Office of Pharmacoviligance and Epidemiology (OPE) Alternate Members: • Gerald DalPan, M.D., M.H.S., Director, OSE • S. Chris Jones, Deputy Director, Division of Pharmacovigilance (DPV) II • Judy Staffa, Ph.D., R.Ph., Associate Director for Public Health Initiatives -Page 1 of 4- April 29, 2021 • Cynthia LaCivita, R.Ph, Director, Division -
JHH 6.3 Nov 09 Layout
Volume 16 Issue 1 Spring 2019 JOURNALOF holistic healthcare Re-imagining healthcare •The nature–human connection •Gaian psychology •Reclaiming nature-based practice •Goethian science •Super-resilience •Ecotherapy for young people •Health and wellbeing through nature •Your world in words •The fractal effect •Nurturing wellbeing •Illuminations of nature •Poetry – Fiona Hamilton – Peter Owen-Jones – Larry Butler Nature connections Your Invitation Weleda Gardens Open Day Sunday 14 July 2019 11am - 4pm The Field, Hassock Lane, Heanor, Derbyshire, DE75 7JH A610 IKEA Langley Mill Station A608 Shipley A6096 A6007 Heanor R The Field oad Ilkeston Weleda Aldi We are Tesco here A6007 A rare opportunity to visit our private gardens and ZLOGĭRZHUPHDGRZWRJHWDQLQVLJKWLQWRWKHSODQWV WKDWDUHDWWKHKHDUWRIRXUSURGXFWV&RPHDORQJ 3URĬWVJRWRVXSSRUWWKHZRUN DQGOHDUQDOODERXW'HUE\VKLUH:LOGOLIH7UXVWWRR RI'HUE\VKLUH:LOGOLIH7UXVW DQGORFDOLQLWLDWLYHV Tickets - Single £5, Family £10 For tickets go to: Derbyshire www.weleda.co.uk/page/openday W i l d l i f e Tr u s t JOURNALOF holistic Contents healthcare ISSN 1743-9493 Editorial . 2 The nature–human connection and health . 3 Published by Alex Laird British Holistic Medical Association Gaian psychology in practice. 7 West Barn, Chewton Keynsham An outcome study of groupwork to address concerns about the world BRISTOL BS31 2SR Chris Johnstone [email protected] www.bhma.org Reclaiming nature-based practice for the modern world . 11 From green care to soulcentric rites of passage Reg. Charity No. 289459 Roger Duncan Managing mental health with nature . 15 Editor-in-chief Paul Brook David Peters The Earth Says (after Hokasai Says) . 18 [email protected] Larry Butler Editorial Board Learning super-resilience from nature . -
When Mentoring Matters
careers & recruitment People Recent moves of note in and around the biotech and pharma industries. over 20 years of experience in the pharma Clinical-stage biopharma Humanigen has announced the industry, including significant gene therapy appointment of Adrian Kilcoyne (photo) to the newly created translational and development expertise. role of chief medical officer. He brings leadership experience Reape was most recently chief medical from multinational pharma and biotech companies and a officer at Spark Therapeutics. strong clinical background in internal medicine and public health medicine, having recently served as vice president of Clinical-stage precision medicine oncology global medical affairs, head of evidence generation company Relay Therapeutics has named and external alliances at AstraZeneca. Patrick Riley senior vice president of “Dr. Kilcoyne’s experience and knowledge in multiple areas, including COVID-19, artificial intelligence. Riley has over a CAR-T and other oncology clinical development areas, medical affairs, regulatory affairs, decade of data science and machine learning evidence generation, health economics and partnering, gives him a unique insight that can experience from Google, initially in web be leveraged towards Humanigen’s COVID-19, acute GvHD, CAR-T and other oncology search and user behavior analysis and programs with lenzilumab and ifabotuzumab,” said Humanigen CEO Cameron Durrant. later as a principal engineer and senior “In addition, Adrian’s leadership in the external alliances arena will be instrumental in researcher on the Google Accelerated helping guide the progress of Humanigen’s pipeline and potential commercialization.” Science team. In addition, Relay has appointed Charles Ferté, formerly AstraZeneca’s senior director and global project leader of oncology R&D, as its Laura Carter has been appointed CSO of Precision metagenomics company vice president and lead for RLY-4008, a Gossamer Bio, succeeding Luisa Salter-Cid. -
Public Health Act
Province of Alberta PUBLIC HEALTH ACT Revised Statutes of Alberta 2000 Chapter P-37 Current as of June 17, 2021 Office Consolidation © Published by Alberta Queen’s Printer Alberta Queen’s Printer Suite 700, Park Plaza 10611 - 98 Avenue Edmonton, AB T5K 2P7 Phone: 780-427-4952 Fax: 780-452-0668 E-mail: [email protected] Shop on-line at www.qp.alberta.ca Copyright and Permission Statement Alberta Queen's Printer holds copyright on behalf of the Government of Alberta in right of Her Majesty the Queen for all Government of Alberta legislation. Alberta Queen's Printer permits any person to reproduce Alberta’s statutes and regulations without seeking permission and without charge, provided due diligence is exercised to ensure the accuracy of the materials produced, and Crown copyright is acknowledged in the following format: © Alberta Queen's Printer, 20__.* *The year of first publication of the legal materials is to be completed. Note All persons making use of this consolidation are reminded that it has no legislative sanction, that amendments have been embodied for convenience of reference only. The official Statutes and Regulations should be consulted for all purposes of interpreting and applying the law. Amendments Not in Force This consolidation incorporates only those amendments in force on the consolidation date shown on the cover. It does not include the following amendments: RSA 2000 cP-37 s77 repeals ss1(1)(e.1) and (2), 33(2.1) and (2.2), 52.6(1.1)(c) and (1.2), 52.61, 52.92 to 52.992, 53(4.2) to (4.4), 53.1 to 53.4, 66(2)(r), 76. -
News and Notes
Med Humanities: first published as 10.1136/mh.26.1.63 on 1 June 2000. Downloaded from J Med Ethics: Medical Humanities 2000;26:63–64 News and Notes In this regular column we will be and members of the public are explor- UK Universities; Sir William Reid, including brief reports, announce- ing collaborative ways forward to former Health Service Commissioner ments and items of news on develop- ensure sustainable educational devel- for England; Baroness Hayman and ments or events of significance to the opment, appropriate standard setting Baroness Jay, former Under- field of medical humanities. In this for group work and for courses and Secretaries of State for Health; the first issue British items feature promi- research, criteria for good professional Right Honourable Chris Smith MP, nently, but the editors welcome mate- practice, improved ways of disseminat- Secretary of State for Culture, Media rial from around the world. Contribu- ing information and better empower- and Sport, and the Right Honourable tors are invited to send material ing of public action. Mr Alan Howarth, MP, Government directly to the editors, David Greaves “Against this background, Sir Ken- Minister for the Arts. and Martyn Evans, Centre for Philos- neth Calman, formerly the UK Chief “In Autumn 1999 the NuYeld ophy and Health Care, School of Medical OYcer and now Vice Chan- Trust helped to establish a Centre for Health Science, University of Wales cellor, Durham University, convened a the Arts and Humanities in Health Swansea, Singleton Park, Swansea meeting in December 1996 to explore and Medicine (CAHHM) at Durham SA2 8PP. -
Corporate Reputation and Competitiveness
Corporate Reputation and Competitiveness Reputation is at the heart of a company’s success. This unique book, from four of the world leaders in reputation research, reveals the very latest thinking about how organ- izations can improve, whether they are in the public, commercial or not-for-profit sector. The philosophy is to match the external (customer) perception of the organization and what they value, to the internal (customer-facing employee) perception and their organ- izational values. Only when these are ‘harmonized’ can the firm be truly competitive. Corporate Reputation and Competitiveness takes the subject of Reputation Management further than any previous text. It covers some familiar ground: dealing with the media, crisis management, the use of logos and other aspects of corporate identity. But it also argues for Reputation Management to be seen as a way of managing the long-term strat- egy of an organization. It presents a new approach to measuring reputation, one that relies on surveying customers and employees on their view of the corporate character. It carries detailed results of studies showing the interaction of customer–employee per- spectives and how and why customer views influence commercial performance. The book introduces the Corporate Reputation Chain – the potential to link staff and customer satisfaction via the organization’s reputation, and to the Corporate Personality Scale – a way of measuring what customers and staff feel about the organization itself. Detailed case studies from a variety of different companies and sectors reveal the prac- tice of Reputation Management. Corporate Reputation and Competitiveness is intended to be useful to both managers and students on postgraduate courses. -
April 7, 2021 Message from Chief Medical Officer on COVID-19
From: Chief Medical Officer Subject: Message from Chief Medical Officer on COVID-19 Vaccine Availability Date: Wednesday, April 7, 2021 6:08:49 PM Attachments: image001.png April 7, 2021 Message from Chief Medical Officer on COVID-19 Vaccine Availability Dear Colleagues, Earlier this week, President Biden announced the timeline for all U.S. adults to be eligible for the COVID-19 vaccine was moved up to April 19, from the original goal of May 1. That means that in just over a week, any adult in our country who wants a vaccine will be eligible to register for one. This news brings us hope and encouragement that we are on the right path to defeat the pandemic. I want to provide as many resources as possible to help you navigate the various pathways for getting the vaccine. As a DHS employee, there are several roads to vaccination. Mission-essential, location-dependent (1A/1B) employees were provided an opportunity to receive the vaccine through our partnership with the Veterans Health Administration (VHA). Currently, 163 VA Medical Centers (VAMCs) across the country are scheduling and vaccinating those 1A/1B employees who opted in. DHS employees also have several options to locate vaccine opportunities in their communities through VaccineFinder.org or local retail pharmacies. NEW: All non-1A/1B DHS employees may present this designation letter to their local vaccine provider immediately as proof of priority eligibility to receive the COVID-19 vaccine as part of the Centers for Disease Control and Prevention’s Phase 1C (essential workforce) recommendation. Note: This designation letter is not for use as part of our VHA partnership, as the VAMCs are completing vaccinations for DHS 1A/1B colleagues only. -
Hunterian Impact Report 2012
Impact Report 2012 Introduction 2012 has been a year of quite considerable The pace of this programme of activity and achievement for The Hunterian in terms of its academic development is relentless but hugely rewarding. and public engagement. Amongst our triumphs we Perhaps most significantly, our University has should mention the renewal and expanded hang recognised The Hunterian as being not only core of the Hunterian Art Gallery and the opening of our business in respect of its contribution to the University’s special exhibition Rembrandt and the Passion, both lead objectives for excellence in research, an to widespread critical acclaim; the publication of the excellent student experience and for helping to extend Antonine Wall Hunterian Treasures volume and of our institution’s global reach and reputation, but it Director’s Choice: The Hunterian; the strengthening of also points to the role of The Hunterian in our collections through a series of major new strengthening the University of Glasgow’s ability to acquisitions; the development of our international transform Scotland through its research, teaching, partnerships through collections exchange and joint outreach and cultural activities in the publication research activity; the launch of a new Hunterian brand University of Glasgow: Enriching Scotland. identity and significantly enhanced investment in Hunterian street presence; and the further expansion I would argue that the progress we have made in of our highly popular student engagement developing our strategy as a leading UK academic programme including the showcasing of the work of museum service, in the new campus-wide partnerships our first cohort of post-graduate Hunterian we have created, in our improved student offer and Associates, to name but a few. -
Global Health, Epidemiology and Genomics
global health, epidemiology and genomics HEALTH CARE SYSTEMS ORIGINAL RESEARCH ARTICLE Competency of peripheral health workers in detection & management of common syndromic conditions under surveillance, North 24 Parganas, West Bengal, India, 2016: a cross-sectional study F. Debnath1,2*, T. Bhatnagar3, L. Sundaramoorthy3 and M. Ponnaiah3 1 Division of Epidemiology, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, West Bengal, India 2 Masters of Public Health Scholar, ICMR-National Institute of Epidemiology, Chennai, India 3 ICMR School of Public Health, ICMR-National Institute of Epidemiology, Chennai, India Global Health, Epidemiology and Genomics (2017), 2, e15, page 1 of 8. doi:10.1017/gheg.2017.13 Background Competency of peripheral health workers in the detection and management of common syndromic condi- tions is crucial as they are the first point of contact for the majority of the Indian population. Methods We measured the competency of auxiliary nurse midwives (ANMs), and factors associated with inadequate competency, in the detection and management of common conditions diarrhoea,̶ acute respiratory tract infection, fever, malaria through̶ a cross-sectional study using condition specific validated clinical vignettes and structured questionnaires. Results Out of 272 selected ANMs, 68% (95% CI 62–74%) were adequately competent. Factors independently associated with inadequate competency were unavailability of essential drugs in preceding month [adjusted odds ratio (AOR) = 1.95; 95% CI 1.1–3.5] and ever trained in integrated management of childhood illness (AOR = 2.4; 95% CI 1.4–4.1). Conclusion More than two third of the peripheral health workers were adequately competent to detect and manage com- mon conditions. -
Dr. Robin Philipp Professor Michael Baum Reverend Andrew Mawson Sir Kenneth Caiman Published by the Nuffield Trust 59 New Cavendish Street London W1M 7RD
Nuffield Trust Series No. 10 Beyond the Millennium Windsor I Cumberland Lodge, Windsor Great Park 12th & 13th March 1998 A summary of the proceedings of the first Windsor Conference Dr. Robin Philipp Professor Michael Baum Reverend Andrew Mawson Sir Kenneth Caiman Published by The Nuffield Trust 59 New Cavendish Street London W1M 7RD Telephone: 0171 631 8450 Facsimile: 0171 631 8451 Email: [email protected] Website: www.nuffieldtrust.org.uk ISBN: 1 902089 24 3 © Nuffield Trust 1999 Publications Committee Professor John Ledingham DM, FRCP Dame Fiona Caldicott, DBE, FRCP, FRCPsych John Wyn Owen, CB CONTENTS Page Foreword 6 Acknowledgements 7 Section 1 The Windsor I Conference 8 The Objectives 11 Section 2 General Background 12 Section 3 Scene setting: Points from the Keynote Presentation of Sir Kenneth Caiman 18 Points from the Keynote Presentation of Sir David Weatherall 20 Section 4 Working group I: Humanities in medical undergraduate education Key points from the Background Working Paper prepared by Group Chairman Professor Michael Baum 24 Writing as a reflective practitioner. Gillie Bolton 39 Notes from Professor Michael Baum's introductory conference presentation 44 Conclusions and recommendations from Group I 47 CONTENTS Section 5 Working group II: Humanities in community development and health Key points from the Background Working Paper prepared by Group Chairman Reverend Andrew Mawson 53 Notes from Reverend Mawson's introductory conference presentation 68 Conclusions and recommendations from Group II 70 Section 6 Working -
MEI Pharma Announces the Retirement of Chief Medical Officer
MEI Pharma Announces the Retirement of Chief Medical Officer Robert Mass and Promotion of Richard Ghalie to Chief Medical Officer SAN DIEGO, April 30, 2021 /PRNewswire/ -- MEI Pharma, Inc. (NASDAQ: MEIP) ("MEI"), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced the retirement of Robert Mass, M.D., MEI's chief medical officer. Dr. Mass joined the company in 2010 and will retire on May 3, 2021, after which he will continue to serve as a strategic advisor to the company. The Company also announced that Richard Ghalie, M.D., MEI's senior vice president, clinical development, has been promoted to chief medical officer. "Bob's contributions to MEI over his more than ten years at the company have been invaluable across our drug candidate pipeline, particularly in guiding the strategy and broad clinical development program for zandelisib, which will best be measured by the benefit these programs may ultimately provide to patients. I want to thank Bob for his dedication to MEI and his friendship over these past 10 years. We wish him the very best in his retirement and look forward to continued interaction through his advisory role," said Daniel P. Gold, Ph.D., president and chief executive officer of MEI Pharma. "I also welcome Richard stepping into his role as our new chief medical officer, a role for which he is very well suited, as evidenced by the significant progress in our zandelisib program under Richard's guidance and its progress with our partners at Kyowa Kirin towards zandelisib's planned new drug application for consideration by FDA for approval under the accelerated approval pathway." Dr. -
Directory of State and Local Government
DIRECTORY OF STATE AND LOCAL GOVERNMENT Prepared by RESEARCH DIVISION LEGISLATIVE COUNSEL BUREAU 2020 Table of Contents TABLE OF CONTENTS Please refer to the Alphabetical Index to the Directory of State and Local Government for a complete list of agencies. NEVADA STATE GOVERNMENT ORGANIZATIONAL CHART ............................................. D-9 CONGRESSIONAL DELEGATION ............................................................................................. D-13 DIRECTORY OF STATE GOVERNMENT CONSTITUTIONAL OFFICERS: Attorney General ........................................................................................................................ D-15 State Controller ........................................................................................................................... D-19 Governor ..................................................................................................................................... D-20 Lieutenant Governor ................................................................................................................... D-27 Secretary of State ........................................................................................................................ D-28 State Treasurer ............................................................................................................................ D-30 EXECUTIVE BOARDS ................................................................................................................. D-31 NEVADA SYSTEM OF HIGHER EDUCATION